These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2661491)

  • 1. Allopathy--the therapeutic legacy.
    Johnston GD
    Ir J Med Sci; 1989 Jan; 158(1):4-9. PubMed ID: 2661491
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reactions in children.
    Fiechtner H
    S D J Med; 1994 Sep; 47(9):325. PubMed ID: 7973598
    [No Abstract]   [Full Text] [Related]  

  • 3. Primum non nocere? Valuing of the risk of drug toxicity in therapeutic decision making.
    Lenert LA; Markowitz DR; Blaschke TF
    Clin Pharmacol Ther; 1993 Mar; 53(3):285-91. PubMed ID: 8453846
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulating reporting of adverse drug reactions by using a fee.
    Feely J; Moriarty S; O'Connor P
    BMJ; 1990 Jan; 300(6716):22-3. PubMed ID: 2105117
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse effects of drugs--their causes and prevention.
    Parke DV
    J R Soc Health; 1985 Apr; 105(2):39-46. PubMed ID: 3921710
    [No Abstract]   [Full Text] [Related]  

  • 6. The legacy of the night before.
    D'Auria D
    Occup Med (Lond); 1994 Dec; 44(5):227-8. PubMed ID: 7841412
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse Drug Reactions.
    Anderson PO
    Breastfeed Med; 2016 Dec; 11():501-503. PubMed ID: 27732053
    [No Abstract]   [Full Text] [Related]  

  • 8. The mathematics of drug dose individualization should be built with random-effects linear models.
    Diaz FJ; de Leon J
    Ther Drug Monit; 2013 Apr; 35(2):276-7. PubMed ID: 23503456
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effects.
    Powell JR
    Pharmacotherapy; 2004 Mar; 24(3):422-5. PubMed ID: 15040659
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models".
    Holford NH; Buclin T
    Ther Drug Monit; 2013 Dec; 35(6):873-4. PubMed ID: 24263647
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic drug monitoring and patient outcome. A review of the issues.
    Tonkin AL; Bochner F
    Clin Pharmacokinet; 1994 Sep; 27(3):169-74. PubMed ID: 7988099
    [No Abstract]   [Full Text] [Related]  

  • 12. Ways to minimize adverse drug reactions. Individualized doses and common sense are key.
    Cohen JS
    Postgrad Med; 1999 Sep; 106(3):163-8, 171-2. PubMed ID: 10494273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The legacy.
    Weinstein LB
    J Gerontol Nurs; 2004 Nov; 30(11):54-6. PubMed ID: 15575192
    [No Abstract]   [Full Text] [Related]  

  • 14. Legacy data sharing to improve drug safety assessment: the eTOX project.
    Sanz F; Pognan F; Steger-Hartmann T; Díaz C; ; Cases M; Pastor M; Marc P; Wichard J; Briggs K; Watson DK; Kleinöder T; Yang C; Amberg A; Beaumont M; Brookes AJ; Brunak S; Cronin MTD; Ecker GF; Escher S; Greene N; Guzmán A; Hersey A; Jacques P; Lammens L; Mestres J; Muster W; Northeved H; Pinches M; Saiz J; Sajot N; Valencia A; van der Lei J; Vermeulen NPE; Vock E; Wolber G; Zamora I
    Nat Rev Drug Discov; 2017 Dec; 16(12):811-812. PubMed ID: 29026211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and adverse reactions to some drugs in dromedary (Camelus dromedarius).
    el Bahri L; Souilem O; Djegham M; Belguith J
    Vet Hum Toxicol; 1999 Feb; 41(1):35-8. PubMed ID: 9949485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectives.
    Cutler NR; Sramek JJ; Greenblatt DJ; Chaikin P; Ford N; Lesko LJ; Davis B; Williams RL
    J Clin Pharmacol; 1997 Sep; 37(9):767-83. PubMed ID: 9549630
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy in the elderly. Excerpts].
    Hach I; Kirch W
    Praxis (Bern 1994); 2008 Sep; 97(18):989-92. PubMed ID: 18807703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Introduction to adverse drug reactions and drug-drug interaction].
    Mikus G
    Ther Umsch; 2011 Jan; 68(1):3-9. PubMed ID: 21184388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: drug induced diseases I.
    Saltiel M
    J Pharm Pract; 2014 Oct; 27(5):429. PubMed ID: 25249587
    [No Abstract]   [Full Text] [Related]  

  • 20. Avoiding adverse drug effects in elderly patients.
    Leipzig RM
    Cleve Clin J Med; 1998 Oct; 65(9):470-8. PubMed ID: 9795488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.